Tango Therapeutics prices $600 million public offering at $30 per share Jun 9, 2026 10:49PM
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering Jun 9, 2026 10:49PM
Tango Therapeutics launches $500 million public stock offering Jun 8, 2026 04:01PM
Tango Therapeutics Announces Proposed $500 Million Public Offering Jun 8, 2026 04:01PM
Tango Therapeutics Inc.'s (TNGX) Vopimetostat Efficacy Impressive: Cantor Fitzgerald Oct 27, 2025 06:44AM


Oct 23, 2025 07:25AM Tango Therapeutics raises $225 million in stock offering
Oct 23, 2025 07:20AM Tango Therapeutics Announces $225 Million Financing
Apr 4, 2024 06:32AM Cantor Fitzgerald Starts Tango Therapeutics Inc. (TNGX) at Overweight, 'A Full Dance Card of Novel Cancer Candidates'